Oklo stock tumbles as Financial Times scrutinizes valuation
Investing.com - TD Cowen has raised its price target on Vital Farms (NASDAQ:VITL) to $59.00 from $48.00 while maintaining a Buy rating on the stock. The new target represents significant upside from the current price of $44.80, with InvestingPro data showing the stock has already delivered an impressive 51.4% return over the past six months.
The research firm cited multiple growth factors supporting the increased valuation, including distribution growth, rising consumer awareness, favorable elasticity, and aggressive capacity expansion plans.
TD Cowen projects an 18% compound annual growth rate (CAGR) for Vital Farms’ sales, reaching $1.8 billion by 2030 with EBITDA of $253 million.
The firm believes potential positive revisions to Vital Farms’ 2027 growth targets could serve as a catalyst for the stock’s performance.
Vital Farms, which produces pasture-raised eggs and other ethically sourced food products, has been expanding its market presence and production capacity to meet increasing consumer demand.
In other recent news, Vital Farms has seen several positive developments. The company reported second-quarter results that surpassed expectations, prompting TD Cowen to raise its price target from $42 to $48 while maintaining a Buy rating. Additionally, Vital Farms has raised its 2025 guidance above consensus estimates. Analysts at DA Davidson also noted that the company exceeded its second-quarter 2025 adjusted EBITDA expectations, reiterating a Buy rating with a $51 price target.
BMO Capital increased its price target for Vital Farms to $60, highlighting the company’s growth potential in the U.S. pasture-raised egg market. Similarly, Mizuho raised its target to $53, citing improvements in supply chain operations and potential sales growth. DA Davidson also adjusted its price target to $52, pointing to improvements in supply and capacity constraints. These recent developments reflect a generally positive outlook among analysts for Vital Farms.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.